Ilex Medical Ltd (TLV:ILX)

Market Cap	703.35M
Revenue (ttm)	920.37M
Net Income (ttm)	38.98M
Shares Out	11.28M
EPS (ttm)	3.49
PE Ratio	15.24
Forward PE	n/a
Dividend	1.36 (2.16%)
Ex-Dividend Date	Apr 7, 2025

Volume	222
Average Volume	8,024
Open	6,322.00
Previous Close	6,322.00
Day's Range	6,126.00 - 6,342.00
52-Week Range	5,643.00 - 8,499.00
Beta	0.08
RSI	46.58
Earnings Date	Mar 27, 2025

About Ilex Medical

Ilex Medical Ltd provides healthcare technological solutions in Israel, South Africa, and internationally. The company offers microbiology, chemistry, molecular biology, immunochemistry, and blood banking solutions. It also offers coagulation, hematology, blood gases, bilirubin, biomarkers, fertility, cellular medicine occult blood, and calprotectin services, as well as provides LIS, urine microscopy, osmolarity, and genetic laboratory services. In addition, the company offers medical automation solutions for microbiology, immunoserology, chemi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1977
• Employees: 223
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: ILX

Financial Performance

In 2024, Ilex Medical's revenue was 920.37 million, a decrease of -1.13% compared to the previous year's 930.89 million. Earnings were 38.98 million, a decrease of -23.39%.